Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · IEX Real-Time Price · USD
4.060
+0.050 (1.25%)
At close: Mar 27, 2024, 4:00 PM
4.140
+0.080 (1.97%)
After-hours: Mar 27, 2024, 7:57 PM EDT

Aptevo Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current20232022202120202019201820172016
Market Capitalization
33123915230299149
Market Cap Growth
--73.01%-69.36%-74.63%412.61%2.85%-68.29%83.89%-
Enterprise Value
-9-8-1913740172913
PE Ratio
-0.18-0.181.47-1.35-8.56-0.73-0.5413.03-0.44
PS Ratio
--3.793.1435.26-1.256.204.95
PB Ratio
0.220.260.6631.709.152.500.951.110.98
P/FCF Ratio
-0.27-0.27-0.56-1.72-5.17-0.70-0.55-2.11-1.25
P/OCF Ratio
-0.27-0.27-0.56-1.78-5.18-0.70-0.56-2.19-1.34
EV/Sales Ratio
---0.410.7331.75-0.761.961.29
EV/EBITDA Ratio
0.490.49-0.14-0.33-8.37-1.06-0.34-2.18-0.10
EV/EBIT Ratio
0.480.48-0.16-0.31-7.71-1.00-0.33-1.76-0.10
EV/FCF Ratio
0.710.710.06-0.40-4.65-0.95-0.33-0.67-0.33
Debt / Equity Ratio
0.440.440.5313.751.651.960.630.230.36
Debt / EBITDA Ratio
-0.32-0.321.07-0.61-1.68-0.61-0.38-1.44-0.14
Debt / FCF Ratio
-0.46-0.46-0.45-0.75-0.93-0.55-0.37-0.44-0.47
Quick Ratio
2.342.342.891.443.090.332.044.502.83
Current Ratio
2.642.643.151.513.250.782.775.143.65
Asset Turnover
000.080.190.1300.270.140.09
Return on Equity (ROE)
-104.80%-104.80%63.10%-346.10%-166.70%-166.90%-108.00%9.80%-161.50%
Return on Assets (ROA)
-60.10%-60.10%21.40%-43.60%-52.70%-62.00%-63.80%6.40%-102.40%
Return on Capital (ROIC)
-163.91%-163.91%-104.12%-119.35%-65.49%-116.93%-103.99%-53.36%-201.27%
Earnings Yield
-639.16%-546.03%67.95%-73.82%-11.68%-136.49%-186.33%7.67%-227.53%
FCF Yield
-430.61%-367.87%-178.20%-58.09%-19.36%-143.53%-181.85%-47.30%-79.69%
Buyback Yield / Dilution
-139.76%-139.76%-8.85%-38.25%-16.25%-81.50%-5.46%-5.41%-0.05%
Total Shareholder Return
-139.76%-139.76%-8.85%-38.25%-16.25%-81.50%-5.46%-5.41%-0.05%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).